Short Interest in NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Increases By 26.0%

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) saw a significant growth in short interest in March. As of March 15th, there was short interest totalling 112,100 shares, a growth of 26.0% from the February 28th total of 89,000 shares. Currently, 2.7% of the company’s stock are sold short. Based on an average daily trading volume, of 226,500 shares, the short-interest ratio is presently 0.5 days.

NovaBay Pharmaceuticals Stock Up 0.0 %

NovaBay Pharmaceuticals stock traded up $0.00 during mid-day trading on Tuesday, reaching $0.59. 112,460 shares of the company were exchanged, compared to its average volume of 208,406. The firm has a market cap of $2.46 million, a P/E ratio of -0.06 and a beta of 2.82. NovaBay Pharmaceuticals has a 12-month low of $0.36 and a 12-month high of $9.08.

NovaBay Pharmaceuticals Company Profile

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.